Cite
HARVARD Citation
Oza, A. et al. (n.d.). Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. Lancet oncology. 16 (1), pp. 87-97. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Oza, A. et al. (n.d.). Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. Lancet oncology. 16 (1), pp. 87-97. [Online].